Revium Rx.

RVRC · OTC · SIC 2834: Pharmaceutical Preparations
7
SEC Filings

Business Summary

PART I . Overview We are a pre-clinical stage biopharmaceutical company focused on the development and eventual commercialization of innovative and proprietary nanoparticle-based therapies. We focus on creating smarter, more targeted treatments that improve how medicines work in the body, with the goal of increasing effectiveness while reducing side effects. We are developing unique lipid-based platforms for a variety of potential uses, including areas with high unmet-needs such as antimicrobial...

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionRVRCdiscussed_in_filing Artificial Intelligence
topic_mentionRVRCdiscussed_in_filing Cybersecurity
topic_mentionRVRCdiscussed_in_filing Trusted Computing
topic_mentionRVRCdiscussed_in_filing Blockchain & Crypto
topic_mentionRVRCdiscussed_in_filing Regulation
topic_mentionRVRCdiscussed_in_filing Healthcare & Bio
topic_mentionRVRCdiscussed_in_filing Platform & Ecosystem
topic_mentionRVRCdiscussed_in_filing Sovereign & Government
topic_mentionRVRCdiscussed_in_filing Artificial Intelligence
topic_mentionRVRCdiscussed_in_filing Cybersecurity
topic_mentionRVRCdiscussed_in_filing Trusted Computing
topic_mentionRVRCdiscussed_in_filing Blockchain & Crypto
topic_mentionRVRCdiscussed_in_filing Regulation
topic_mentionRVRCdiscussed_in_filing Healthcare & Bio
topic_mentionRVRCdiscussed_in_filing Platform & Ecosystem
topic_mentionRVRCdiscussed_in_filing Sovereign & Government
topic_mentionRVRCdiscussed_in_filing Artificial Intelligence
topic_mentionRVRCdiscussed_in_filing Cybersecurity
topic_mentionRVRCdiscussed_in_filing Trusted Computing
topic_mentionRVRCdiscussed_in_filing Blockchain & Crypto

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001213900-26-037573EDGAR81K words

Quarterly Reports (10-Q)

No 10-Q filings indexed.

7 total filings indexed. 6 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001839140
TickerRVRC
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f0d711cb1901ea44239d0e79df9820a535035e01c3381e77d49c9356fc16b30e
parent: f3ff987449ce5929c5e46d347b0037a11c5e2f104f9e2d5b6b2e760fe2958e15
content hash: 9989507e01012c5d03eadc678b992bca7bb230a29802c1b50339393db48e3a12
signed: 2026-04-13T04:47:17.009Z
sources: 1 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf